Putting Stakeholder Engagement at the Center of Health Economic Modeling for Health Technology Assessment in the United States
IVI economists and staff recently published this open-access article describing specifically how IVI puts stakeholder engagement at the center of value assessment. Read about the engagement process IVI is using to build patient-centricity into its major depressive disorder (MDD) health economic model below or on download a copy from PharmacoEconomics here. Putting Stakeholder Engagement at […]
IVI Shares Executive Summary of Annual Methods Summit
The national dialogue on value in health care is bringing to the forefront the limitations of current value assessment methods and gaps in real world data to inform decision-making. IVI seeks to engage a wider group of stakeholders to inform priorities in methods research and to invest resources and expertise in improving value assessment. Toward […]
Reforming Medicare’s Dialysis Payment Policies: Implications for Patients with Secondary Hyperparathyroidism
Expanding services covered by a “bundled payment” can also expand variation in the costs of treating patients under the bundle. In this article, Charu Gupta et al.explore this topic further using the Medicare dialysis program as an example. Source: Health Services Research
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
The PRISMA statement is a reporting guideline designed to improve the completeness of reporting of systematic reviews and meta-analyses. Authors have used this guideline worldwide to prepare their reviews for publication. In the past, these reports typically compared 2 treatment alternatives. With the evolution of systematic reviews that compare multiple treatments, some of them only […]
Special Issue of AJMC on HCV: Access, Value, and Cost of Innovative Therapies
In a special issue of The American Journal of Managed Care (AJMC) on the Hepatitis C virus, released May 2016, IVI authors take up multiple key issues at the intersection of access, cost, and value from recent innovations in HCV treatment in four separate articles: “Does Patient Cost Sharing for HCV Drug Make Sense?” authored by Darius Lakdawalla, […]
Neumann and Co-authors Respond to ASCO Value Framework
In an article published in the Journal of Clinical Oncology, Peter Neumann and other members of ISPOR respond to ASCO’s revised framework for value assessment in cancer. Source: Journal of Clinical Oncology
IVI and Health Affairs Launch New Featured Topic Series on Health Affairs Blog
Health Affairs blog, in collaboration with IVI, today launched a new featured topic series titled “Drugs and Medical Innovation.” As Health Affairs blog editor Chris Fleming notes in an introductory post, the areas of drugs and medical innovation “have long been central in health care and health policy, and recent developments have heightened their importance even more. The […]
IVI Releases Protocol for Report on Cost-Effectiveness Analysis in Health Care
IVI released the research protocol for its first project, which examines the quality of evidence and methods used in cost-effectiveness analysis (CEA) in healthcare. The research protocol is available here. This is the first research project in a series that will look at issues of relevance to policy, value assessment practices or methods, economic questions related […]
IVI Report Examines Imbalances in Health Care Effectiveness Analyses
A new Innovation and Value Initiative (IVI) report found that cost-effectiveness analyses (CEAs) are disproportionately conducted on pharmaceutical interventions compared to other health care treatments. Learn more about what causes this and the potential policy solutions to achieve better overall balance of CEAs across health care interventions. Read more about the project and results here.
IVI Releases Public Feedback on Open-Source Value Project Model for Rheumatoid Arthritis
Today, the Innovation and Value Initiative (IVI) released public feedback on the IVI Open-Source Value Project model for rheumatoid arthritis. IVI launched the Open-Source Value Project, a first-of-its-kind effort to better measure value in health care treatments, with the release of an open-source tool focused on measuring value in treatments for RA. The IVI-RA model […]